Matt Wilsey
Secretary & Trustee
Matt Wilsey is CEO of Grace Science, LLC, a biotechnology company focused on drug development in pediatric rare diseases as well as oncology and neurodegenerative diseases in adults. Matt is also the volunteer president of Grace Science Foundation, a non-profit working to cure the rare genetic disease called NGLY1 Deficiency.
Before Grace Science, Matt spent many years as a front-line executive. Most recently, he was co-founder and chief revenue officer of CardSpring, a payment infrastructure company that was acquired by Twitter. Previously, he ran West coast sales and business development for Howcast.com. Before Howcast, Matt worked for Kohlberg Kravis Roberts (KKR) on the Capital Markets team focused on new product development, capital raising, and investor relations. Prior to that, Matt spent five years as co-founder and vice president of business development at Zazzle.com. He started his career serving in various roles at the White House and the Department of Defense.
Matt holds a B.A. from Stanford University and a M.B.A. from Stanford’s Graduate School of Business. In addition to serving as a trustee of the Charles and Helen Schwab Foundation, he is a fellow at Stanford University's School of Medicine and sits on the Scientific Advisory Council of Stanford University's Research Office.